- Home
- ZYXI vs CNTB Comparison
ZYXI vs CNTB Comparison
Compare ZYXI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- CNTB
- Stock Information
- Founded
- ZYXI 1996
- CNTB 2012
- Country
- ZYXI United States
- CNTB United States
- Employees
- ZYXI N/A
- CNTB N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- CNTB Health Care
- Exchange
- ZYXI Nasdaq
- CNTB Nasdaq
- Market Cap
- ZYXI 66.5M
- CNTB 55.2M
- IPO Year
- ZYXI N/A
- CNTB 2021
- Fundamental
- Price
- ZYXI $2.18
- CNTB $0.74
- Analyst Decision
- ZYXI Buy
- CNTB Strong Buy
- Analyst Count
- ZYXI 3
- CNTB 1
- Target Price
- ZYXI $10.25
- CNTB $8.00
- AVG Volume (30 Days)
- ZYXI 262.3K
- CNTB 258.1K
- Earning Date
- ZYXI 04-29-2025
- CNTB 03-31-2025
- Dividend Yield
- ZYXI N/A
- CNTB N/A
- EPS Growth
- ZYXI N/A
- CNTB N/A
- EPS
- ZYXI 0.09
- CNTB N/A
- Revenue
- ZYXI $192,354,000.00
- CNTB $26,033,000.00
- Revenue This Year
- ZYXI N/A
- CNTB N/A
- Revenue Next Year
- ZYXI $23.16
- CNTB N/A
- P/E Ratio
- ZYXI $24.22
- CNTB N/A
- Revenue Growth
- ZYXI 4.36
- CNTB N/A
- 52 Week Low
- ZYXI $1.93
- CNTB $0.51
- 52 Week High
- ZYXI $12.19
- CNTB $2.08
- Technical
- Relative Strength Index (RSI)
- ZYXI 26.14
- CNTB 50.81
- Support Level
- ZYXI $2.03
- CNTB $0.60
- Resistance Level
- ZYXI $2.24
- CNTB $1.00
- Average True Range (ATR)
- ZYXI 0.18
- CNTB 0.13
- MACD
- ZYXI 0.17
- CNTB 0.03
- Stochastic Oscillator
- ZYXI 38.46
- CNTB 46.73
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.